FENNEC ANNOUNCES RESULTS OF ANNUAL MEETING

June 08, 2016

Research Triangle Park, NC — (Marketwired) – June 8, 2016– Fennec Pharmaceuticals Inc. (TSX: FRX, OTCQB: FENCF) today announced that the nominees listed in the management proxy circular dated May 9, 2016 (the “Circular”) for the Annual Meeting of Shareholders were elected as directors of the Company at the Annual Meeting of Shareholders held in Boston, Massachusetts on June 8, 2016 (the “Meeting”).  Detailed results of the vote for the election of directors are set out below:


Name of Nominee
Votes For
% Votes For
Votes Withheld
% Votes Withheld
Dr. Khalid Islam 5,960,408 99.95% 2,856   0.05%
Mr. Adrian Haigh 5,960,335 99.95% 2,929   0.05%
Mr. Chris A. Rallis 5,960,335 99.95% 2,929   0.05%
Mr. Rostislav Raykov 5,960,335 99.95% 2,929   0.05%

 

For further information, please contact:

Rosty Raykov
Chief Executive Officer
Fennec Pharmaceuticals Inc.
T: (919) 636-5144